Bank Julius Baer & Co. Ltd Zurich Grows Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Bank Julius Baer & Co. Ltd Zurich lifted its position in shares of DocuSign, Inc. (NASDAQ:DOCU) by 8.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,506 shares of the company’s stock after buying an additional 190 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich’s holdings in DocuSign were worth $249,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Toronto Dominion Bank boosted its position in DocuSign by 30.3% during the third quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock worth $1,624,000 after acquiring an additional 6,081 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of DocuSign by 1.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock worth $82,478,000 after purchasing an additional 16,014 shares during the last quarter. Quantinno Capital Management LP grew its position in shares of DocuSign by 39.5% in the third quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock valued at $12,514,000 after purchasing an additional 57,104 shares during the period. Rhumbline Advisers grew its position in shares of DocuSign by 118.8% in the fourth quarter. Rhumbline Advisers now owns 608,123 shares of the company’s stock valued at $54,695,000 after purchasing an additional 330,136 shares during the period. Finally, KBC Group NV increased its stake in DocuSign by 32.7% in the fourth quarter. KBC Group NV now owns 1,535,107 shares of the company’s stock valued at $138,067,000 after purchasing an additional 378,233 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.

DocuSign Trading Down 2.5 %

NASDAQ:DOCU opened at $77.86 on Tuesday. The firm’s fifty day simple moving average is $88.78 and its 200 day simple moving average is $78.90. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The firm has a market capitalization of $15.73 billion, a price-to-earnings ratio of 16.05, a PEG ratio of 6.94 and a beta of 1.02.

Insider Buying and Selling at DocuSign

In other DocuSign news, insider Robert Chatwani sold 14,800 shares of the stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $97.76, for a total value of $1,446,848.00. Following the completion of the sale, the insider now owns 73,414 shares of the company’s stock, valued at $7,176,952.64. This trade represents a 16.78 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of the business’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $86.90, for a total transaction of $695,200.00. Following the transaction, the chief financial officer now directly owns 77,851 shares in the company, valued at approximately $6,765,251.90. The trade was a 9.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 104,422 shares of company stock valued at $9,665,394 over the last three months. 1.66% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

DOCU has been the topic of a number of research analyst reports. Royal Bank of Canada reissued a “sector perform” rating and issued a $90.00 price target (up from $57.00) on shares of DocuSign in a research note on Friday, December 6th. HSBC reissued a “reduce” rating on shares of DocuSign in a research report on Friday, December 6th. Robert W. Baird upped their price target on shares of DocuSign from $59.00 to $100.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. UBS Group lifted their price target on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Finally, Piper Sandler boosted their price objective on shares of DocuSign from $60.00 to $90.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, DocuSign currently has an average rating of “Hold” and an average target price of $92.91.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.